
FARALLON CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | EXEL | 19.50M | $805.41M |
![]() | RVMD | 14.63M | $683.02M |
![]() | TNGX | 10.76M | $90.36M |
![]() | HIMS | 10.75M | $609.56M |
![]() | BEAM | 10.06M | $244.23M |
![]() | ARMK | 9.00M | $345.45M |
![]() | LQDA | 8.57M | $194.78M |
![]() | BBIO | 8.19M | $425.49M |
![]() | PTGX | 6.20M | $411.60M |
![]() | AGIO | 5.78M | $232.05M |
![]() | CRNX | 5.77M | $240.32M |
![]() | VNET | 5.49M | $56.70M |
![]() | DIS | 5.20M | $595.28M |
![]() | TEVA | 5.00M | $100.94M |
![]() | NYT | 4.99M | $286.18M |
![]() | PRME | 4.75M | $26.32M |
![]() | BSX | 4.75M | $463.41M |
![]() | TRU | 4.73M | $396.45M |
![]() | CNTA | 4.33M | $105.03M |
![]() | BBNX | 4.31M | $85.72M |

Exelixis, Inc.
EXEL
Shares Held
19.50M
Value
$805.41M

Revolution Medicines, Inc.
RVMD
Shares Held
14.63M
Value
$683.02M

Tango Therapeutics, Inc.
TNGX
Shares Held
10.76M
Value
$90.36M

Hims & Hers Health, Inc.
HIMS
Shares Held
10.75M
Value
$609.56M

Beam Therapeutics Inc.
BEAM
Shares Held
10.06M
Value
$244.23M

Aramark
ARMK
Shares Held
9.00M
Value
$345.45M

Liquidia Corporation
LQDA
Shares Held
8.57M
Value
$194.78M

BridgeBio Pharma, Inc.
BBIO
Shares Held
8.19M
Value
$425.49M

Protagonist Therapeutics, Inc.
PTGX
Shares Held
6.20M
Value
$411.60M

Agios Pharmaceuticals, Inc.
AGIO
Shares Held
5.78M
Value
$232.05M

Crinetics Pharmaceuticals, Inc.
CRNX
Shares Held
5.77M
Value
$240.32M

VNET Group, Inc.
VNET
Shares Held
5.49M
Value
$56.70M

The Walt Disney Company
DIS
Shares Held
5.20M
Value
$595.28M

Teva Pharmaceutical Industries Limited
TEVA
Shares Held
5.00M
Value
$100.94M

The New York Times Company
NYT
Shares Held
4.99M
Value
$286.18M

Prime Medicine, Inc.
PRME
Shares Held
4.75M
Value
$26.32M

Boston Scientific Corporation
BSX
Shares Held
4.75M
Value
$463.41M

TransUnion
TRU
Shares Held
4.73M
Value
$396.45M

Centessa Pharmaceuticals plc
CNTA
Shares Held
4.33M
Value
$105.03M

Beta Bionics, Inc.
BBNX
Shares Held
4.31M
Value
$85.72M
